Benjamin Graham fit · Defensive deep-value investing
Is Anbio Biotechnology Class A Ordinary Shares (NNNN) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
23/100
FNot a fit
3/7 criteria passed
Benjamin Graham's Criteria, Applied to NNNN
P/E ≤ 15
key—
P/B ≤ 1.5
key0.7x
Current ratio ≥ 2
211.1x
Debt / Equity ≤ 1
0.0x
How NNNN Scores on Other Strategies
Live Financial Snapshot
Market cap
$278.27M
P/E (TTM)
171.9x
ROIC (TTM)
21.48%
Gross margin
87.06%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is NNNN's Benjamin Graham fit score?
NNNN scores 23/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own NNNN?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends NNNN.
How often is this score updated?
NNNN's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends NNNN.